Association between tau H2 haplotype and age at onset in frontotemporal dementia

被引:32
作者
Borroni, B
Yancopoulou, D
Tsutsui, M
Padovani, A
Sawcer, SJ
Hodges, JR
Spillantini, MG
机构
[1] Univ Cambridge, Dept Clin Neurosci, Brain Repair Ctr, Cambridge CB2 2PY, England
[2] Univ Cambridge, Dept Clin Neurosci, Neurol Unit, Cambridge CB2 2PY, England
[3] Univ Brescia, Dept Med Sci, Neurol Clin, Brescia, Italy
关键词
D O I
10.1001/archneur.62.9.1419
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The frontotemporal dementia (FTD) syndromes have been associated with the microtubule-associated tau protein since tau gene mutations have been demonstrated to be the cause of FTD and parkinsonism. linked to chromosome 17. In cases of FTD without tau gene mutations, however, it is unclear whether genetic variability in the tau gene is associated with the development or modulation of FTD. Objective: To determine whether genetic variability in tau and apolipoprotein E (ApoE) modulates and contributes to the development of FTD. Design and Patients: The distribution of tau gene haplotypes and the ApoE genotype were investigated in 86 patients with well-characterized FTD and 50 control subjects. Results: No difference in the distribution of the tau H1 and H2 haplotypes between FTD cases and controls was observed, whereas the ApoE epsilon 4 allele was more frequent in FTD cases. The. presence of at least 1 tau H2 allele was found to be significantly associated with an earlier age of onset in patients with FTD. The association between the H2 allele and age at onset was not related to family history, clinical presentation, or ApoE genotype. Conclusion: These findings support a role of tau protein in modulating disease phenotype by influencing the age at onset in these FTD cases.
引用
收藏
页码:1419 / 1422
页数:4
相关论文
共 20 条
  • [1] APOE and modulation of Alzheimer's and frontotemporal dementia
    Boccardi, M
    Sabattoli, F
    Testa, C
    Beltramello, A
    Soininen, H
    Frisoni, GB
    [J]. NEUROSCIENCE LETTERS, 2004, 356 (03) : 167 - 170
  • [2] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
    CORDER, EH
    SAUNDERS, AM
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. SCIENCE, 1993, 261 (5123) : 921 - 923
  • [3] ALLELE EPSILON-4 OF APOLIPOPROTEIN-E SHOWS A DOSE-EFFECT ON AGE AT ONSET OF PICK DISEASE
    FARRER, LA
    ABRAHAM, CR
    VOLICER, L
    FOLEY, EJ
    KOWALL, NW
    MCKEE, AC
    WELLS, JM
    [J]. EXPERIMENTAL NEUROLOGY, 1995, 136 (02) : 162 - 170
  • [4] Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia
    Gustafson, L
    Abrahamson, M
    Grubb, A
    Nilsson, K
    Fex, G
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (04) : 240 - 243
  • [5] Survival in frontotemporal dementia
    Hodges, JR
    Davies, R
    Xuereb, J
    Kril, J
    Halliday, G
    [J]. NEUROLOGY, 2003, 61 (03) : 349 - 354
  • [6] HODGES JR, 2001, NEUROLOGY S4, V56, P6
  • [7] Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
    Hughes, A
    Mann, D
    Pickering-Brown, S
    [J]. EXPERIMENTAL NEUROLOGY, 2003, 181 (01) : 12 - 16
  • [8] Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E ε4
    Ingelson, M
    Fabre, SF
    Lilius, L
    Andersen, C
    Viitanen, M
    Almkvist, O
    Wahlund, LO
    Lannfelt, L
    [J]. NEUROREPORT, 2001, 12 (05) : 905 - 909
  • [9] Keppel G., 1991, Design and analysis: A researcher's handbook, V3rd
  • [10] Tau haplotypes regulate transcription and are associated with Parkinson's disease
    Kwok, JBJ
    Teber, ET
    Loy, C
    Hallupp, M
    Nicholson, G
    Mellick, GD
    Buchanan, DD
    Silburn, PA
    Schofield, PR
    [J]. ANNALS OF NEUROLOGY, 2004, 55 (03) : 329 - 334